Skip to main content


Embolus permanent protector stent-filter Worldwide, stroke is the number three cause of death and the number one cause of adult disability. More women die of stroke than breast cancer. Today, there is no viable treatment for stroke. There are two kinds of strokes, ischemic which involves a clot (85% of...
Read More


Fast and Reliable ultra-sensitive Identification of Streptococcus B at deliverY Sepsis, pneumonia and sometimes meningitis caused by Group B Streptococcus (GBS) are the most common severe bacterial diseases in infants. They account for high morbidity and mortality rates; despite the extent of implemented prevention strategies, GBS is still the leading...
Read More


The health sector sees the emergence of new generations of innovative therapies, among which promising approaches are related to gene and cell therapies. This evolution often leads to the deployment of patient-centric processes, implying not only dramatic changes in the bio-production processes but also significant increases of the treatment costs....
Read More


3D Printed Biomaterials and OPTimized for Regeneration Oral Bone Bone regeneration is frequently used in dentistry especially in implantology. The use of biomaterials for bone regeneration or alveolar bone preservation is a reliable treatment option compared to autologous bone involving higher morbidity. However, the commercially available biomaterials for dental bone...
Read More


Treatment of breast cancer with epigenetic specific tools The partners of the TREATBEST consortium are joining forces in order to leverage disruptive science in the field of personalized breast cancer treatment. The final product will be a CE-marked IVD test predicting the treatment benefit for patients with triple-negative breast cancer,...
Read More


Identification of drug candidates and biomarkers for immunotherapy (cancer and autoimmune diseases) IT-Targets project aims to identify innovative drugs candidates and biomarkers for cancer immunotherapy and auto-immune diseases in order to improve the response of patients to immunotherapy. The strategy is based on sampling human clinical samples, purify the different...
Read More


Optimization of the treatment with HepaMune in fibro-inflammatory chronic liver diseases The aim of the IMPROVE project is to develop a new cell therapy product that will be used for the treatment of fibro-inflammatory chronic liver diseases. The objective is to develop a product exhibiting increased immuno-modulatory and anti-inflammatory potential,...
Read More


Development and validation of a local treatment for cervix cancer resulting from human papillomavirus infection The main objective of the project is the development of an effective and safe local treatment, of the lesions of the cervix induced by HPV infection. This project results from the identification of a medical...
Read More

Secure your place for BioWin Day: empowering health, the premier event for professionals and decision-makers in the life sciences industry.

Register here!